91¸£Àû

The 91¸£Àû’s research commercialisation wing, 91¸£Àû Innovations, has signed a contract with agronomy specialist Agrii to promote the commercial production of UK haricot beans developed by scientists at the 91¸£Àû.

An international team of scientists working at the 91¸£Àû, UK, and Monash University, Australia, have determined the molecular basis of a biological mechanism that could enable more efficient and cost-effective production of existing antibiotics, and also allow scientists to uncover new antibiotics in soil bacteria.

91¸£Àû joins forces with leading UK universities to focus agricultural research where it can make most difference on the ground

Researchers at the 91¸£Àû have uncovered the mechanism that allows plants to pass on their ‘memories’ to offspring, which results in growth and developmental defects.

A computational model of a human lung cell has been used to understand how SARS-CoV-2 draws on human host cell metabolism to reproduce by researchers at the 91¸£Àû. This study helps understand how the virus uses the host to survive, and enable drug predictions for treating the virus to be made.

· A hallmark of Parkinson's disease is the degeneration of a group of neurons in the brain that release the neurotransmitter dopamine (dopaminergic neurons).  By introducing low concentrations of structurally-defined aggregates of alpha synuclein, a key toxic species in Parkinson’s disease, into single dopaminergic neurons, researchers from the 91¸£Àû have shown these protein aggregates open a specific channel in the cell membrane, reducing neuronal excitability. Furthermore they’ve shown that this can be partially prevented by pre-application of the commonly used anti-diabetic drug, glibenclamide.